AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

Tracy T. Batchelor, A. Gregory Sorensen, Emmanuelle di Tomaso, Wei Ting Zhang, Dan G G. Duda, Kenneth S. Cohen, Kevin R. Kozak, Daniel P. Cahill, Poe Jou Chen, Mingwang Zhu, Marek Ancukiewicz, Maciej M. Mrugala, Scott Plotkin, Jan Drappatz, David N. Louis, Percy Ivy, David T T. Scadden, Thomas Benner, Jay S. Loeffler, Patrick Y. WenRakesh K. Jain

Research output: Contribution to journalArticlepeer-review

1439 Scopus citations

Fingerprint

Dive into the research topics of 'AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients'. Together they form a unique fingerprint.

Medicine & Life Sciences